Skip to main content
OpenTrials
Completed

NCT Number: NCT03969459

Impact of Exposure to Persistent Organic Pollutants During Pregnancy on the Composition of Breast Milk and Consequences on the Newborn

Epidemiological studies link early exposure to persistent organic pollutants (POPs) with health consequences in the newborn. Experimental studies have shown the impact of POPs on the gut microbiota. This project aims to characterize the POPs content in breast milk in an exposed population and to evaluate the impact on breast milk composition and intestinal microbiota establishment in the newborn. The health consequences will be evaluated by the clinical follow-up of the newborn.

Completed

Looking for future studies?

Notify Me

Key information

Age range

1 day–1 day

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU Amiens

Amiens, 80000, France

About this study

Picardie is a sub-region with a young population and a high birth rate. The highlighting and the characterization of a maternal exhibition and the newborn will make it possible to know the in utero and postnatal exposure to the pesticides, and if necessary, to implement measures of information and prevention adapted to limit it.

The study of pesticide exposure in the periconceptional period, ante and postnatal is crucial because of the vulnerability of this period to the environment and its immediate consequences on the health of the child but also in the long term on the development of chronic pathologies in adulthood. This study will allow us to assess the impact of POPs on the installation of the intestinal microbiota of newborn.

100 mother-child pairs will be included in this project. Samples of 20 mL of breast milk, meconium and stool of newborns will be taken. Gas chromatography or liquid phase analyzes coupled with mass spectrometry will be carried out on breast milk to evaluate the content of persistent organic pollutants and to isolate them. An analysis of the chemical composition of each milk sample will be performed. A bacteriological study for the enumeration of the germs in the mother's milk on the one hand then in the meconium and the saddles of the new-born on the other part will be realized. The DNA of isolated and identified germs will be compared by molecular biology techniques to determine their identity or non-identity within the microbiota of breast milk, meconium and newborn stool. The impact of breast milk contamination by pesticides on the health of newborn will be studied

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • newborn born before 33 weeks of amenorrhea or at term born at least 37 weeks of amenorrhea
  • mother aged of 18 to 42 years old at the time of inclusion
  • mother not deprived of parental rights
  • signed concerned consent
  • mother having lived for at least 6 months in the Picardie subregion

Exclusion criteria

  • newborn whose term of birth is between 33 and 37 weeks of amenorrhea
  • mother minor or aged over 42 years
  • mother deprived of her parental rights

Treatment and study plan

breast milk collection

Biological

3 samples of 20 ml of breast milk will be collected between day 0 and day 4; between day 7 and day 15; and between day 21 and day 30 after childbirth.

meconium collection

Biological

3 samples of 20 ml of meconium milk will be collected between day 0 and day 4; between day 7 and day 15; and between day 21 and day 30 after childbirth.

newborn feces collection

Biological

3 samples of 20 ml of newborn feces will be collected between day 0 and day 4; between day 7 and day 15; and between day 21 and day 30 after childbirth.

questionary of pesticide exposure of the mother

Other

maternal questionary of pesticide exposure of the mother

Primary outcomes

  1. measure of quantity of pesticides in mother's milk

    Time frame: between day 0 and day 4 after childbirth

    the evaluation of the contamination of the mother's milk by pesticides will be done on 20 ml sample of breast milk.

  2. measure of quantity of pesticides in mother's milk

    Time frame: between day 7 and day 15 after childbirth

    the evaluation of the contamination of the mother's milk by pesticides will be done on 20 ml sample of breast milk.

  3. measure of quantity of pesticides in mother's milk

    Time frame: between day 21 and day 30 after childbirth

    the evaluation of the contamination of the mother's milk by pesticides will be done on 20 ml sample of breast milk.

Secondary outcomes

  1. correlation between measure of quantity of pesticides in mother's milk and microbiota composition in mother's milk

    Time frame: between day 0 and day 4 after childbirth

    correlation between pesticides contamination of mother's milk and microbiota composition in mother's milk

  2. correlation between measure of quantity of pesticides in mother's milk and microbiota composition in mother's milk

    Time frame: between day 7 and day 15 after childbirth

    correlation between pesticides contamination of mother's milk and microbiota composition in mother's milk

  3. correlation between measure of quantity of pesticides in mother's milk and microbiota composition in mother's milk

    Time frame: between day 21 and day 30 after childbirth

    correlation between pesticides contamination of mother's milk and microbiota composition in mother's milk

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire, Amiens

Other

Registry information

Acronym: PESTIMICOBLAIT

Important dates

Study start
2019
Primary completion
2021
Study completion
2023
First posted
May 31, 2019
Registry last updated
Mar 22, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.